Happy Holidays from the RWJ Hamilton family
Home Contact Directions
 
About Us Medical Services HealthConnection Employment Guide Your complete source for health information
 


CINJ Hamilton


Active Research Studies for PANCREATIC CANCER

Metastatic Pancreatic Cancer
CINJ 070501
(NJ 1205): A Phase II Study of Imatinib Mesylate and Gemcitabine For The First-line Treatment of Metastatic Pancreatic Cancer